Kevin P Starr - Net Worth and Insider Trading

Kevin P Starr Net Worth

The estimated net worth of Kevin P Starr is at least $1.3 Billion dollars as of 2024-09-20. Kevin P Starr is the 10% Owner of Global Blood Therapeutics Inc and owns about 8,843,448 shares of Global Blood Therapeutics Inc (GBT) stock worth over $606 Million. Kevin P Starr is the 10% Owner of Blueprint Medicines Corp and owns about 5,453,753 shares of Blueprint Medicines Corp (BPMC) stock worth over $496 Million. Kevin P Starr is also the Director, 10% Owner of MyoKardia Inc and owns about 826,001 shares of MyoKardia Inc (MYOK) stock worth over $186 Million. Besides these, Kevin P Starr also holds Agios Pharmaceuticals Inc (AGIO) , Editas Medicine Inc (EDIT) , CytomX Therapeutics Inc (CTMX) , Sage Therapeutics Inc (SAGE) , Zafgen Inc (ZFGN) , Alnylam Pharmaceuticals Inc (ALNY) . Details can be seen in Kevin P Starr's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kevin P Starr has not made any transactions after 2018-04-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Kevin P Starr

Kevin P Starr Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kevin P Starr owns 24 companies in total, including Revolution Medicines Inc (RVMD) , Nurix Therapeutics Inc (NRIX) , and Relay Therapeutics Inc (RLAY) among others .

Click here to see the complete history of Kevin P Starr’s form 4 insider trades.

Insider Ownership Summary of Kevin P Starr

Ticker	Comapny	Transaction Date	Type of Owner
RVMD	Revolution Medicines Inc	2020-02-12	10 percent owner
NRIX	Nurix Therapeutics Inc	2020-07-23	10 percent owner
RLAY	Relay Therapeutics Inc	2020-07-15	10 percent owner
		2018-04-18	director & 10 percent owner
		2020-06-02	10 percent owner
		2019-07-17	10 percent owner
		2016-12-19	10 percent owner
		2017-10-04	10 percent owner
		2018-08-22	10 percent owner
		2018-06-29	10 percent owner
		2018-03-07	director & 10 percent owner
		2017-11-01	10 percent owner
		2017-04-12	10 percent owner
		2016-12-16	10 percent owner
		2015-11-12	director
		2016-12-19	10 percent owner
		2017-01-26	10 percent owner
		2016-09-06	10 percent owner
		2015-07-13	director & 10 percent owner
		2015-05-14	10 percent owner
		2014-05-30	director
		2014-02-05	10 percent owner
		2021-02-11	10 percent owner
		2014-02-05	10 percent owner

Kevin P Starr Latest Holdings Summary

Kevin P Starr currently owns a total of 9 stocks. Among these stocks, Kevin P Starr owns 8,843,448 shares of Global Blood Therapeutics Inc (GBT) as of December 16, 2016, with a value of $606 Million and a weighting of 45.29%. Kevin P Starr owns 5,453,753 shares of Blueprint Medicines Corp (BPMC) as of December 19, 2016, with a value of $496 Million and a weighting of 37.09%. Kevin P Starr also owns 826,001 shares of MyoKardia Inc (MYOK) as of January 3, 2018, with a value of $186 Million and a weighting of 13.89%. The other 6 stocks Agios Pharmaceuticals Inc (AGIO) , Editas Medicine Inc (EDIT) , CytomX Therapeutics Inc (CTMX) , Sage Therapeutics Inc (SAGE) , Zafgen Inc (ZFGN) , Alnylam Pharmaceuticals Inc (ALNY) have a combined weighting of 3.74% among all his current holdings.

Latest Holdings of Kevin P Starr

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
GBT	Global Blood Therapeutics Inc	2016-12-16	8,843,448	68.49	605,687,754
BPMC	Blueprint Medicines Corp	2016-12-19	5,453,753	90.95	496,018,835
MYOK	MyoKardia Inc	2018-01-03	826,001	224.91	185,775,885
AGIO	Agios Pharmaceuticals Inc	2013-07-23	545,454	47.38	25,843,611
EDIT	Editas Medicine Inc	2016-09-06	3,906,176	3.93	15,351,272
CTMX	CytomX Therapeutics Inc	2017-04-12	5,201,767	1.17	6,086,067
SAGE	Sage Therapeutics Inc	2018-04-18	340,179	7.91	2,690,816
ZFGN	Zafgen Inc	2015-09-24	30,860	0.99	30,551
ALNY	Alnylam Pharmaceuticals Inc	2015-11-12	0	276.33	0

Holding Weightings of Kevin P Starr

Kevin P Starr Form 4 Trading Tracker

According to the SEC Form 4 filings, Kevin P Starr has made a total of 0 transactions in Global Blood Therapeutics Inc (GBT) over the past 5 years. The most-recent trade in Global Blood Therapeutics Inc is the sale of 108,955 shares on December 16, 2016, which brought Kevin P Starr around $2 Million.

According to the SEC Form 4 filings, Kevin P Starr has made a total of 0 transactions in Blueprint Medicines Corp (BPMC) over the past 5 years. The most-recent trade in Blueprint Medicines Corp is the sale of 106,489 shares on December 19, 2016, which brought Kevin P Starr around $3 Million.

According to the SEC Form 4 filings, Kevin P Starr has made a total of 0 transactions in MyoKardia Inc (MYOK) over the past 5 years. The most-recent trade in MyoKardia Inc is the sale of 816,326 shares on January 3, 2018, which brought Kevin P Starr around $34 Million.

More details on Kevin P Starr's insider transactions can be found in the Insider Trading History of Kevin P Starr table.

Insider Trading History of Kevin P Starr

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kevin P Starr Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Kevin P Starr Ownership Network

Ownership Network List of Kevin P Starr

No Data

Ownership Network Relation of Kevin P Starr

Kevin P Starr Owned Company Details

What does Revolution Medicines Inc do?

Who are the key executives at Revolution Medicines Inc?

Kevin P Starr is the 10 percent owner of Revolution Medicines Inc. Other key executives at Revolution Medicines Inc include General Counsel Jeff Cislini , See Remarks Margaret A Horn , and Chief Financial Officer Jack Anders .

Revolution Medicines Inc (RVMD) Insider Trades Summary

Over the past 18 months, Kevin P Starr made no insider transaction in Revolution Medicines Inc (RVMD). Other recent insider transactions involving Revolution Medicines Inc (RVMD) include a net sale of 169,725 shares made by Stephen Michael Kelsey , a net sale of 22,044 shares made by Jeff Cislini , and a net sale of 97,940 shares made by Margaret A Horn .

In summary, during the past 3 months, insiders sold 142,631 shares of Revolution Medicines Inc (RVMD) in total and bought 0 shares, with a net sale of 142,631 shares. During the past 18 months, 510,129 shares of Revolution Medicines Inc (RVMD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 510,129 shares.

Revolution Medicines Inc (RVMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Revolution Medicines Inc Insider Transactions

No Available Data

What does Nurix Therapeutics Inc do?

Who are the key executives at Nurix Therapeutics Inc?

Kevin P Starr is the 10 percent owner of Nurix Therapeutics Inc. Other key executives at Nurix Therapeutics Inc include General Counsel Christine Ring , Chief Financial Officer Houte Hans Van , and Chief Scientific Officer Gwenn Hansen .

Nurix Therapeutics Inc (NRIX) Insider Trades Summary

Over the past 18 months, Kevin P Starr made no insider transaction in Nurix Therapeutics Inc (NRIX). Other recent insider transactions involving Nurix Therapeutics Inc (NRIX) include a net sale of 45,727 shares made by Christine Ring , a net sale of 76,829 shares made by Houte Hans Van , and a net sale of 12,402 shares made by Gwenn Hansen .

In summary, during the past 3 months, insiders sold 62,735 shares of Nurix Therapeutics Inc (NRIX) in total and bought 0 shares, with a net sale of 62,735 shares. During the past 18 months, 135,300 shares of Nurix Therapeutics Inc (NRIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 135,300 shares.

Nurix Therapeutics Inc (NRIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Nurix Therapeutics Inc Insider Transactions

No Available Data

What does Relay Therapeutics Inc do?

Who are the key executives at Relay Therapeutics Inc?

Kevin P Starr is the 10 percent owner of Relay Therapeutics Inc. Other key executives at Relay Therapeutics Inc include See remarks Peter Rahmer , Vice President & Finance Thomas Catinazzo , and See Remarks Donald A Bergstrom .

Relay Therapeutics Inc (RLAY) Insider Trades Summary

Over the past 18 months, Kevin P Starr made no insider transaction in Relay Therapeutics Inc (RLAY). Other recent insider transactions involving Relay Therapeutics Inc (RLAY) include a net sale of 132,938 shares made by Peter Rahmer , a net sale of 31,695 shares made by Thomas Catinazzo , and a net sale of 20,199 shares made by Donald A Bergstrom .

In summary, during the past 3 months, insiders sold 154,742 shares of Relay Therapeutics Inc (RLAY) in total and bought 0 shares, with a net sale of 154,742 shares. During the past 18 months, 282,730 shares of Relay Therapeutics Inc (RLAY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 282,730 shares.

Relay Therapeutics Inc (RLAY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Relay Therapeutics Inc Insider Transactions

No Available Data

What does Sage Therapeutics Inc do?

Who are the key executives at Sage Therapeutics Inc?

Kevin P Starr is the director & 10 percent owner of Sage Therapeutics Inc. Other key executives at Sage Therapeutics Inc include director & See Remarks Jeffrey M Jonas , Chief Medical Officer Laura Gault , and Chief Commercial Officer Christopher Benecchi .

Sage Therapeutics Inc (SAGE) Insider Trades Summary

Over the past 18 months, Kevin P Starr made no insider transaction in Sage Therapeutics Inc (SAGE). Other recent insider transactions involving Sage Therapeutics Inc (SAGE) include a net purchase of 3,000 shares made by Elizabeth Barrett ,

In summary, during the past 3 months, insiders sold 0 shares of Sage Therapeutics Inc (SAGE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sage Therapeutics Inc (SAGE) were sold and 3,000 shares were bought by its insiders, resulting in a net purchase of 3,000 shares.

Sage Therapeutics Inc (SAGE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sage Therapeutics Inc Insider Transactions

No Available Data

What does Pliant Therapeutics Inc do?

Who are the key executives at Pliant Therapeutics Inc?

Kevin P Starr is the 10 percent owner of Pliant Therapeutics Inc. Other key executives at Pliant Therapeutics Inc include Chief Business Officer Hans Hull , Chief Medical Officer Eric Lefebvre , and Chief Financial Officer Keith Lamont Cummings .

Pliant Therapeutics Inc (PLRX) Insider Trades Summary

Over the past 18 months, Kevin P Starr made no insider transaction in Pliant Therapeutics Inc (PLRX). Other recent insider transactions involving Pliant Therapeutics Inc (PLRX) include a net sale of 81,578 shares made by Hans Hull , a net sale of 38,137 shares made by Mike Ouimette , and a net sale of 169,920 shares made by Bernard Coulie .

In summary, during the past 3 months, insiders sold 79,496 shares of Pliant Therapeutics Inc (PLRX) in total and bought 0 shares, with a net sale of 79,496 shares. During the past 18 months, 396,238 shares of Pliant Therapeutics Inc (PLRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 396,238 shares.

Pliant Therapeutics Inc (PLRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Pliant Therapeutics Inc Insider Transactions

No Available Data

What does Fulcrum Therapeutics Inc do?

Who are the key executives at Fulcrum Therapeutics Inc?

Kevin P Starr is the 10 percent owner of Fulcrum Therapeutics Inc. Other key executives at Fulcrum Therapeutics Inc include Controller Greg Tourangeau , director & See Remarks Alex Sapir , and Chief Financial Officer Alan A Musso .

Fulcrum Therapeutics Inc (FULC) Insider Trades Summary

Over the past 18 months, Kevin P Starr made no insider transaction in Fulcrum Therapeutics Inc (FULC). Other recent insider transactions involving Fulcrum Therapeutics Inc (FULC) include a net sale of 5,330 shares made by Greg Tourangeau , and a net purchase of 43,360 shares made by Alex Sapir .

In summary, during the past 3 months, insiders sold 0 shares of Fulcrum Therapeutics Inc (FULC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,330 shares of Fulcrum Therapeutics Inc (FULC) were sold and 43,360 shares were bought by its insiders, resulting in a net purchase of 38,030 shares.

Fulcrum Therapeutics Inc (FULC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Fulcrum Therapeutics Inc Insider Transactions

No Available Data

What does Voyager Therapeutics Inc do?

Who are the key executives at Voyager Therapeutics Inc?

Kevin P Starr is the 10 percent owner of Voyager Therapeutics Inc. Other key executives at Voyager Therapeutics Inc include Chief Operating Officer Robin Swartz , Chief Scientific Officer Todd Alfred Carter , and Chief Financial Officer Peter P. Pfreundschuh .

Voyager Therapeutics Inc (VYGR) Insider Trades Summary

Over the past 18 months, Kevin P Starr made no insider transaction in Voyager Therapeutics Inc (VYGR). Other recent insider transactions involving Voyager Therapeutics Inc (VYGR) include a net sale of 21,233 shares made by Todd Alfred Carter , a net sale of 9,125 shares made by Robin Swartz , and a net sale of 32,585 shares made by Alfred Sandrock .

In summary, during the past 3 months, insiders sold 0 shares of Voyager Therapeutics Inc (VYGR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 80,274 shares of Voyager Therapeutics Inc (VYGR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 80,274 shares.

Voyager Therapeutics Inc (VYGR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Voyager Therapeutics Inc Insider Transactions

No Available Data

What does Rhythm Pharmaceuticals Inc do?

Who are the key executives at Rhythm Pharmaceuticals Inc?

Kevin P Starr is the 10 percent owner of Rhythm Pharmaceuticals Inc. Other key executives at Rhythm Pharmaceuticals Inc include Chief Human Resources Officer Pamela J. Cramer , Chief Technical Officer Joseph Shulman , and Corporate Controller & CAO Christopher Paul German .

Rhythm Pharmaceuticals Inc (RYTM) Insider Trades Summary

Over the past 18 months, Kevin P Starr made no insider transaction in Rhythm Pharmaceuticals Inc (RYTM). Other recent insider transactions involving Rhythm Pharmaceuticals Inc (RYTM) include a net sale of 171,662 shares made by Joseph Shulman , a net sale of 78,894 shares made by Jennifer Chien , and a net sale of 75,787 shares made by Pamela J. Cramer .

In summary, during the past 3 months, insiders sold 191,981 shares of Rhythm Pharmaceuticals Inc (RYTM) in total and bought 0 shares, with a net sale of 191,981 shares. During the past 18 months, 583,578 shares of Rhythm Pharmaceuticals Inc (RYTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 583,578 shares.

Rhythm Pharmaceuticals Inc (RYTM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Rhythm Pharmaceuticals Inc Insider Transactions

No Available Data

What does Constellation Pharmaceuticals Inc do?

Who are the key executives at Constellation Pharmaceuticals Inc?

Kevin P Starr is the 10 percent owner of Constellation Pharmaceuticals Inc. Other key executives at Constellation Pharmaceuticals Inc include Chief Financial Officer Emma Reeve , 10 percent owner Column Group L P , and See Remarks Karen Valentine .

Constellation Pharmaceuticals Inc (CNST) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Constellation Pharmaceuticals Inc (CNST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Constellation Pharmaceuticals Inc (CNST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Constellation Pharmaceuticals Inc (CNST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Constellation Pharmaceuticals Inc Insider Transactions

No Available Data

What does Neon Therapeutics Inc do?

Who are the key executives at Neon Therapeutics Inc?

Kevin P Starr is the 10 percent owner of Neon Therapeutics Inc. Other key executives at Neon Therapeutics Inc include President of R&D Richard Gaynor , director & 10 percent owner Robert I Tepper , and Chief Financial Officer Yasir B. Al-wakeel .

Neon Therapeutics Inc (NTGN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Neon Therapeutics Inc (NTGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neon Therapeutics Inc (NTGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Neon Therapeutics Inc (NTGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Neon Therapeutics Inc Insider Transactions

No Available Data

What does MyoKardia Inc do?

Who are the key executives at MyoKardia Inc?

Kevin P Starr is the director & 10 percent owner of MyoKardia Inc. Other key executives at MyoKardia Inc include director & President and CEO Anastasios Gianakakos , General Counsel Denelle J Waynick , and Chief Business Officer Jake Bauer .

MyoKardia Inc (MYOK) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of MyoKardia Inc (MYOK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MyoKardia Inc (MYOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

MyoKardia Inc (MYOK)'s detailed insider trading history can be found in Insider Trading Tracker table.

MyoKardia Inc Insider Transactions

No Available Data

What does Allena Pharmaceuticals Inc do?

Who are the key executives at Allena Pharmaceuticals Inc?

Kevin P Starr is the 10 percent owner of Allena Pharmaceuticals Inc. Other key executives at Allena Pharmaceuticals Inc include See Remarks Louis Md Brenner , Chief Financial Officer Richard D Katz , and Chief Financial Officer Edward Wholihan .

Allena Pharmaceuticals Inc (ALNAQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Allena Pharmaceuticals Inc (ALNAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Allena Pharmaceuticals Inc (ALNAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Allena Pharmaceuticals Inc (ALNAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Allena Pharmaceuticals Inc Insider Transactions

No Available Data

What does CytomX Therapeutics Inc do?

Who are the key executives at CytomX Therapeutics Inc?

Kevin P Starr is the 10 percent owner of CytomX Therapeutics Inc. Other key executives at CytomX Therapeutics Inc include SVP & Chief Scientific Officer Marcia Belvin , SVP & Finance and Accounting Christopher Ogden , and Chief Financial Officer Jeffrey B Landau .

CytomX Therapeutics Inc (CTMX) Insider Trades Summary

Over the past 18 months, Kevin P Starr made no insider transaction in CytomX Therapeutics Inc (CTMX). Other recent insider transactions involving CytomX Therapeutics Inc (CTMX) include a net sale of 62,273 shares made by Sean A. Mccarthy , a net sale of 25,172 shares made by Marcia Belvin , and a net sale of 19,012 shares made by Lloyd A Rowland .

In summary, during the past 3 months, insiders sold 28,425 shares of CytomX Therapeutics Inc (CTMX) in total and bought 0 shares, with a net sale of 28,425 shares. During the past 18 months, 132,341 shares of CytomX Therapeutics Inc (CTMX) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 127,341 shares.

CytomX Therapeutics Inc (CTMX)'s detailed insider trading history can be found in Insider Trading Tracker table.

CytomX Therapeutics Inc Insider Transactions

No Available Data

What does Global Blood Therapeutics Inc do?

Who are the key executives at Global Blood Therapeutics Inc?

Kevin P Starr is the 10 percent owner of Global Blood Therapeutics Inc. Other key executives at Global Blood Therapeutics Inc include Chief Financial Officer Jeffrey S Farrow , See Remarks Nazila Habibizad , and Chief Human Resources Officer Carrie Krehlik .

Global Blood Therapeutics Inc (GBT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Global Blood Therapeutics Inc (GBT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Global Blood Therapeutics Inc (GBT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Global Blood Therapeutics Inc (GBT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Global Blood Therapeutics Inc Insider Transactions

No Available Data

What does Alnylam Pharmaceuticals Inc do?

Who are the key executives at Alnylam Pharmaceuticals Inc?

Kevin P Starr is the director of Alnylam Pharmaceuticals Inc. Other key executives at Alnylam Pharmaceuticals Inc include EVP & Chief Commercial Officer Yvonne Greenstreet , EVP & Chief Commercial Officer Tolga Tanguler , and CMO & EVP Dev & Med Affairs Pushkal Garg .

Alnylam Pharmaceuticals Inc (ALNY) Insider Trades Summary

Over the past 18 months, Kevin P Starr made no insider transaction in Alnylam Pharmaceuticals Inc (ALNY). Other recent insider transactions involving Alnylam Pharmaceuticals Inc (ALNY) include a net sale of 60,146 shares made by Yvonne Greenstreet , a net sale of 14,598 shares made by Pushkal Garg , and a net sale of 6,616 shares made by Jeffrey V. Poulton .

In summary, during the past 3 months, insiders sold 135,278 shares of Alnylam Pharmaceuticals Inc (ALNY) in total and bought 0 shares, with a net sale of 135,278 shares. During the past 18 months, 269,382 shares of Alnylam Pharmaceuticals Inc (ALNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 269,382 shares.

Alnylam Pharmaceuticals Inc (ALNY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Alnylam Pharmaceuticals Inc Insider Transactions

No Available Data

What does Blueprint Medicines Corp do?

Who are the key executives at Blueprint Medicines Corp?

Kevin P Starr is the 10 percent owner of Blueprint Medicines Corp. Other key executives at Blueprint Medicines Corp include director & CEO & President Jeffrey W. Albers , Principal FAO Michael Landsittel , and Chief Commercial Officer Philina Lee .

Blueprint Medicines Corp (BPMC) Insider Trades Summary

Over the past 18 months, Kevin P Starr made no insider transaction in Blueprint Medicines Corp (BPMC). Other recent insider transactions involving Blueprint Medicines Corp (BPMC) include a net sale of 165,808 shares made by Jeffrey W. Albers , a net sale of 38,146 shares made by Michael Landsittel , and a net sale of 14,415 shares made by Ariel Hurley .

In summary, during the past 3 months, insiders sold 152,725 shares of Blueprint Medicines Corp (BPMC) in total and bought 0 shares, with a net sale of 152,725 shares. During the past 18 months, 461,233 shares of Blueprint Medicines Corp (BPMC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 461,233 shares.

Blueprint Medicines Corp (BPMC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Blueprint Medicines Corp Insider Transactions

No Available Data

What does Jounce Therapeutics Inc do?

Who are the key executives at Jounce Therapeutics Inc?

Kevin P Starr is the 10 percent owner of Jounce Therapeutics Inc. Other key executives at Jounce Therapeutics Inc include 10 percent owner Concentra Merger Sub, Inc. , 10 percent owner Concentra Biosciences, Llc , and director & CEO and President Richard /ca/ Murray .

Jounce Therapeutics Inc (JNCE) Insider Trades Summary

Over the past 18 months, Kevin P Starr made no insider transaction in Jounce Therapeutics Inc (JNCE). Other recent insider transactions involving Jounce Therapeutics Inc (JNCE) include a net sale of 39,228 shares made by Richard /ca/ Murray ,

In summary, during the past 3 months, insiders sold 0 shares of Jounce Therapeutics Inc (JNCE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 39,228 shares of Jounce Therapeutics Inc (JNCE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 39,228 shares.

Jounce Therapeutics Inc (JNCE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Jounce Therapeutics Inc Insider Transactions

No Available Data

What does Editas Medicine Inc do?

Who are the key executives at Editas Medicine Inc?

Kevin P Starr is the 10 percent owner of Editas Medicine Inc. Other key executives at Editas Medicine Inc include SVP & CHIEF MEDICAL OFFICER Baisong Mei , director & CEO Gilmore Neil O'neill , and EVP & CHIEF SCIENTIFIC OFFICER Linda Burkly .

Editas Medicine Inc (EDIT) Insider Trades Summary

Over the past 18 months, Kevin P Starr made no insider transaction in Editas Medicine Inc (EDIT). Other recent insider transactions involving Editas Medicine Inc (EDIT) include a net sale of 2,791 shares made by Bruce Eaton , a net sale of 32,292 shares made by Baisong Mei , and a net sale of 98,056 shares made by Gilmore Neil O'neill .

In summary, during the past 3 months, insiders sold 20,578 shares of Editas Medicine Inc (EDIT) in total and bought 0 shares, with a net sale of 20,578 shares. During the past 18 months, 168,311 shares of Editas Medicine Inc (EDIT) were sold and 45,000 shares were bought by its insiders, resulting in a net sale of 123,311 shares.

Editas Medicine Inc (EDIT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Editas Medicine Inc Insider Transactions

No Available Data

What does Larimar Therapeutics Inc do?

Who are the key executives at Larimar Therapeutics Inc?

Kevin P Starr is the director & 10 percent owner of Larimar Therapeutics Inc. Other key executives at Larimar Therapeutics Inc include 10 percent owner & other: Possible Member of 10% Group James E Flynn , Chief Development Officer Gopi Shankar , and Chief Medical Officer Russell Clayton .

Larimar Therapeutics Inc (LRMR) Insider Trades Summary

Over the past 18 months, Kevin P Starr made no insider transaction in Larimar Therapeutics Inc (LRMR). Other recent insider transactions involving Larimar Therapeutics Inc (LRMR) include a net purchase of 4,290,617 shares made by James E Flynn , a net purchase of 57,208 shares made by Thomas Edward Hamilton , and a net purchase of 5,000 shares made by Carole Ben-maimon .

In summary, during the past 3 months, insiders sold 0 shares of Larimar Therapeutics Inc (LRMR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Larimar Therapeutics Inc (LRMR) were sold and 4,367,575 shares were bought by its insiders, resulting in a net purchase of 4,367,575 shares.

Larimar Therapeutics Inc (LRMR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Larimar Therapeutics Inc Insider Transactions

No Available Data

What does Foundation Medicine Inc do?

Who are the key executives at Foundation Medicine Inc?

Kevin P Starr is the 10 percent owner of Foundation Medicine Inc. Other key executives at Foundation Medicine Inc include director & 10 percent owner & other: See footnote (1) Roche Holding Ltd , director & 10 percent owner & other: See footnote (1) Roche Finance Ltd , and Chief Commercial Officer Thomas Civik .

Foundation Medicine Inc (FMI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Foundation Medicine Inc (FMI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Foundation Medicine Inc (FMI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Foundation Medicine Inc (FMI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Foundation Medicine Inc Insider Transactions

No Available Data

What does Agios Pharmaceuticals Inc do?

Who are the key executives at Agios Pharmaceuticals Inc?

Kevin P Starr is the director of Agios Pharmaceuticals Inc. Other key executives at Agios Pharmaceuticals Inc include director & Chief Executive Officer Brian Goff , Chief Medical Officer Sarah Gheuens , and Principal Accounting Officer Washburn Theodore James Jr. .

Agios Pharmaceuticals Inc (AGIO) Insider Trades Summary

Over the past 18 months, Kevin P Starr made no insider transaction in Agios Pharmaceuticals Inc (AGIO). Other recent insider transactions involving Agios Pharmaceuticals Inc (AGIO) include a net sale of 9,416 shares made by Washburn Theodore James Jr. , a net sale of 64,534 shares made by Brian Goff , and a net sale of 14,160 shares made by James William Burns .

In summary, during the past 3 months, insiders sold 14,796 shares of Agios Pharmaceuticals Inc (AGIO) in total and bought 0 shares, with a net sale of 14,796 shares. During the past 18 months, 286,417 shares of Agios Pharmaceuticals Inc (AGIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 286,417 shares.

Agios Pharmaceuticals Inc (AGIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Agios Pharmaceuticals Inc Insider Transactions

No Available Data

What does Sesen Bio Inc do?

Who are the key executives at Sesen Bio Inc?

Kevin P Starr is the 10 percent owner of Sesen Bio Inc. Other key executives at Sesen Bio Inc include 10 percent owner Modernatx, Inc. , Chief Financial Officer Richard Steven Morris , and director & President and CEO Steven Kelly .

Sesen Bio Inc (SESN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sesen Bio Inc (SESN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sesen Bio Inc (SESN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sesen Bio Inc (SESN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sesen Bio Inc Insider Transactions

No Available Data

What does Decibel Therapeutics Inc do?

Who are the key executives at Decibel Therapeutics Inc?

Kevin P Starr is the 10 percent owner of Decibel Therapeutics Inc. Other key executives at Decibel Therapeutics Inc include See Remarks James B Murphy , See Remarks Anna Trask , and director & See Remarks Laurence Reid .

Decibel Therapeutics Inc (DBTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Decibel Therapeutics Inc (DBTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Decibel Therapeutics Inc (DBTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Decibel Therapeutics Inc (DBTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Decibel Therapeutics Inc Insider Transactions

No Available Data

What does CARISMA Therapeutics Inc do?

Who are the key executives at CARISMA Therapeutics Inc?

Kevin P Starr is the 10 percent owner of CARISMA Therapeutics Inc. Other key executives at CARISMA Therapeutics Inc include 10 percent owner Modernatx, Inc. , Chief Financial Officer Richard Steven Morris , and director & President and CEO Steven Kelly .

CARISMA Therapeutics Inc (CARM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of CARISMA Therapeutics Inc (CARM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CARISMA Therapeutics Inc (CARM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CARISMA Therapeutics Inc (CARM)'s detailed insider trading history can be found in Insider Trading Tracker table.

CARISMA Therapeutics Inc Insider Transactions

No Available Data

Kevin P Starr Mailing Address

Above is the net worth, insider trading, and ownership report for Kevin P Starr. You might contact Kevin P Starr via mailing address: 29 Newbury Street, 3rd Floor, Boston Ma 02116.

Discussions on Kevin P Starr

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.